Concomitant etoposide and cisplatin provided improved survival compared with docetaxel and cisplatin in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy

Presently, there is no consensus regarding which chemotherapy regimen is best to administer with radiotherapy in patients with locally advanced non-small-cell lung cancer (LA-NSCLC). Herein, our aim was to compare the outcome of patients treated with either etoposide–cisplatin (EP) or docetaxel–cisp...

Descripción completa

Detalles Bibliográficos
Autores principales: Sen, Fatma, Tambas, Makbule, Ozkaya, Kubra, Guveli, Murat Emin, Ciftci, Rumeysa, Ozkan, Berker, Oral, Ethem Nezih, Saglam, Esra Kaytan, Saip, Pinar, Toker, Alper, Demir, Adalet, Firat, Pinar, Aydiner, Adnan, Eralp, Yesim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5265838/
https://www.ncbi.nlm.nih.gov/pubmed/27472701
http://dx.doi.org/10.1097/MD.0000000000004280

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5265838/
https://www.ncbi.nlm.nih.gov/pubmed/27472701
http://dx.doi.org/10.1097/MD.0000000000004280

Ejemplares similares